Clinical Trials Browser

Phase 1 × cirmtuzumab × Breast × Clear all

NCT02776917 2025-08-07

Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer

Phase 1 Completed

23 enrolled 10 charts

Breast Neoplasms